NEW YORK – Allelica, a startup developer of software for polygenic risk scoring, has closed a $1.75 million round of seed funding. Valor Ventures, which led the round, announced the investment Thursday.
Other investors include Pi Campus and the Munich, Germany-based Medical Genetics Center (MGZ).
An Allelica spokesperson confirmed to GenomeWeb Thursday that the company is moving its headquarters from Rome to New York. Allelica CEO Giordano Bottà said in a statement that North America represents the firm's largest market.